Biontech And Dualitybio Announce Topline Results Of Global Phase 3 Clinical Trial for Breast Cancer
Biontech And Dualitybio Announce Topline Results Of Global Phase 3 Clinical Trial for Breast Cancer TradingView
Онкология
🎗️Лента новостей
Онкология
Antengene presents clinical trial results for oncology pipeline at ESMO - Vietnam Investment Review
Antengene presents clinical trial results for oncology pipeline at ESMO Vietnam Investment Review - VIR
Онкология
Most advanced breast cancer patients treated in community settings, Phesi study finds
Most advanced breast cancer patients treated in community settings, Phesi study finds Pharmafile
🎗️
Онкология
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer WBOC TV
🎗️
Онкология
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer - Carroll County Mirror-Democrat
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer Carroll County Mirror-Democrat
Онкология
Maria Maddalena Laterza: The Challenges in Biomarker Testing in Gastroesophageal Cancer
Maria Maddalena Laterza: The Challenges in Biomarker Testing in Gastroesophageal Cancer Oncodaily
Онкология
SMART-KEY at ESMO 2026: Pembrolizumab-Based Strategy Achieves 65.1% Laryngectomy-Free Survival in Advanced Laryngeal Cancer
SMART-KEY at ESMO 2026: Pembrolizumab-Based Strategy Achieves 65.1% Laryngectomy-Free Survival in Advanced Laryngeal Cancer Oncodaily
🎗️
Онкология
Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer
Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer NPR
Онкология
Рак молочной железы — не приговор: истории трёх армянских женщин — от страха до надежды - АМИ "Новости-Армения"
Рак молочной железы — не приговор: истории трёх армянских женщин — от страха до надежды АМИ "Новости-Армения"
Онкология
Персонализированная вакцина против меланомы снизила риск рецидива или смерти на 42% - New-Science.ru
Персонализированная вакцина против меланомы снизила риск рецидива или смерти на 42% New-Science.ru
Онкология
Опухоль сама готовит себе яд: японские учёные испытали необычный способ борьбы с раком на клетках
Опухоль сама готовит себе яд: японские учёные испытали необычный способ борьбы с раком на клетках Правда.Ру
Онкология
Новая надежда для онкологических больных благодаря беспрецедентной вакцине.
Новая надежда для онкологических больных благодаря беспрецедентной вакцине. Vietnam.vn
Онкология
Menna Fouda: What Should Oncologists Know About mRNA Cancer Vaccines?
Menna Fouda: What Should Oncologists Know About mRNA Cancer Vaccines? Oncodaily
Онкология
New lung cancer drug adds nearly six months of survival stomach cancer treatment doubles it
New lung cancer drug adds nearly six months of survival stomach cancer treatment doubles it Ynetnews
Онкология
This pancreatic cancer drug may extend lives — if patients can afford it | CBC News
This pancreatic cancer drug may extend lives — if patients can afford it | CBC News CBC